drugset / Trial / NCT02579876

Milk Patch for Eosinophilic Esophagitis

NCT02579876 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single-site, double-blind, placebo-controlled, randomized trial to study efficacy and safety of the Viaskin® Milk Patch for children with milk induced Eosinophilic Esophagitis (EoE). 20 subjects will be randomized 3:1 to Viaskin® Milk or placebo patch.

Timeline

Start
2015-10
Primary completion
2017-12-20
Completion
2018-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Viaskin Milk Protein / enzyme biologic 500 ug Other